Vectus Biosystems Limited (ASX:VBS)
0.0490
+0.0010 (2.08%)
Nov 20, 2026, 3:24 PM AEDT
Vectus Biosystems Market Cap
Vectus Biosystems has a market cap or net worth of 3.05 million as of November 19, 2026. It is the 47,869th most valuable company in the world and the 1,615th biggest in Australia. Its market cap has decreased by 64.29% in one year.
Market Cap
3.05M
Enterprise Value
76.97K
Revenue
2.77M
Global Rank
Country Rank
#1,615 Australia
PE Ratio
1.74
ChartMarket Cap Chart
Since February 23, 2016, Vectus Biosystems's market cap has decreased from 36.22M to 3.05M, a decrease of -91.59%. That is a compound annual growth rate of -20.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.05M | -68.32% |
| Dec 31, 2025 | 9.62M | 134.56% |
| Dec 23, 2024 | 4.10M | -74.31% |
| Dec 29, 2023 | 15.96M | -58.89% |
| Dec 30, 2022 | 38.83M | -15.39% |
| Dec 31, 2021 | 45.89M | 20.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cambium Bio | 10.30M |
| Tissue Repair | 6.65M |
| Bio-Gene Technology | 6.57M |
| AdAlta | 6.42M |
| Invex Therapeutics | 6.39M |
| Zelira Therapeutics | 5.95M |
| Acrux | 5.90M |
| Biotron | 4.18M |